The RE-UNITE-PN Study Design – A Prospective, Non-Interventional, Phase 4 Study of Nemolizumab for the Treatment of Prurigo Nodularis. (2026). SKIN The Journal of Cutaneous Medicine, 10(2), s767. https://doi.org/10.25251/q0ctfz86